Skip to content
Deak Research Group at Drexel

Deak Research Group at Drexel

Leveraging Chemistry to Modulate Immunity

Menu
  • Research
    • Synergistic Combinations of Agonists and Inhibitors for Tolerogenic DCs
    • Targeted Adjuvants for Chronic Viral Infections
  • People
    • Principle Investigator- Peter Deak, PhD
  • Publications
Menu

Research

My research combines Chemistry, Engineering and Immunology to generate novel immunomodulatory translational technologies. We are mainly focused on modulating Dendritic Cell phenotypes with chemistry and biomaterials to generate novel therapies for autoimmune diseases, transplant rejection and therapeutic vaccines.

We have several exciting projects starting up!

  1. Synergistic Combinations of Agonists and Inhibitors for Generation of Tolerogenic APCs

2. Targeted Adjuvants for Chronic Viral Infections

Recent Posts

  • New publication in Biomaterials
  • New Grant to Study Microparticles for Kidney Transplantation
  • New Publication in Frontiers in Medicine
  • New Review Published in Frontiers in Immunology
  • Deak Lab wins NIH R56 Award

Recent Comments

No comments to show.

Archives

  • April 2026
  • February 2025
  • September 2023
  • December 2022
  • November 2022
  • August 2022

Categories

  • Uncategorized
©2026 Deak Research Group at Drexel | Built using WordPress and Responsive Blogily theme by Superb